RBI unveils framework for FPI to FDI investment reclassification

The Reserve Bank of India (RBI) has introduced an operational framework for the reclassification of investments made by Foreign Portfolio Investors (FPIs) to Foreign Direct Investment (FDI). This move is designed to address cases where an FPI, along with its investor group invests more than the pre-determined limit.

Also ReadACME Solar India IPO allotment on November 11; Here’s how you can check status

Current FPI Investment Limit and Breach Consequences

Currently, FPIs are allowed to hold less than 10% of the total paid-up equity capital of an Indian company on a fully diluted basis. If this limit is breached, the FPI has the option to either divest its excess holdings or reclassify them as FDI. This reclassification must be done within five trading days from the date of settlement of the trades that caused the breach, subject to conditions set by the RBI and the Securities and Exchange Board of India (SEBI).

According to the framework, FPIs opting for reclassification will need to secure necessary approvals from the Indian government and the investee company. Additionally, reclassification will not be permitted in sectors where FDI is prohibited.

Also ReadSwiggy IPO to list on November 13: Here are 6 things to know before listing

The RBI has specified that the entire investment must be reported as per the Foreign Exchange Management (Mode of Payment and Reporting of Non-Debt Instruments) Regulations, 2019. Once reporting is complete, the FPI must approach its custodian to transfer the equity instruments from its demat account for foreign portfolio investments to a demat account designated for holding FDI.

 » Read More

Related Articles

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s

WazirX’s $235 million hack: Crypto exchange gets Singapore court nod to repay customer funds

Cryptocurrency exchange WazirX, owned by Singapore-based Zettai Pte Ltd, has received approval from the Singapore High Court to convene a scheme meeting with its users to repay them funds stolen in a $235 million hack in July last year. North Korean Lazarus group was found responsible for the cyberattack. A scheme meeting is a shareholders’

Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks

Indian equity indices opened Thursday’s trading session gap-down. The NSE Nifty 50 opened 35 points, or 0.15%, lower at 23,120.95, while the BSE Sensex fell 106 points, or 0.14%, to open at 76,298.96. Hindustan Unilever’s share price declined by 3%. However, both indices soon started to trade in the green. At 10 am around, the